Gemeinschaftspraxis Panagiotou/Minaei (GbR)
About Gemeinschaftspraxis Panagiotou/Minaei (GbR)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Gemeinschaftspraxis Panagiotou/Minaei (GbR)
During the past decade, Gemeinschaftspraxis Panagiotou/Minaei (GbR) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Rituximab to Treat Chronic Renal Transplant Rejection
2007-01-01
2017-04-01
Completed
62
Carotid Endarterectomy Versus Carotid Artery Stenting in Asymptomatic Patients
2008-01-01
2020-12-01
Unknown status
3,600
IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients
2012-05-01
2031-03-01
Active, not recruiting
504
Efficacy and Safety of Idelalisib in Combination With Obinutuzumab Compared to Chlorambucil in Combination With Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia
2015-04-21
2016-05-13
Terminated
57
Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Adults With Previously Untreated Chronic Lymphocytic Leukemia
2014-02-05
2016-06-16
Terminated
311
Comparing Different Treatments in Reducing Dissociative Seizure Occurrence
2014-10-01
2018-06-01
Completed
368
Safety and Feasibility Evaluation of Robot Assisted Physiotherapy Exercises With REX
2015-05-01
2016-12-01
Completed
56
PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer
2014-05-01
2020-06-01
Unknown status
140
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Gemeinschaftspraxis Panagiotou/Minaei (GbR)"
#1 collaborator was "Roche Pharma AG" with 2 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Gemeinschaftspraxis Panagiotou/Minaei (GbR)
According to Clinical.Site data, the most researched conditions in "Gemeinschaftspraxis Panagiotou/Minaei (GbR)" are
"Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC" (1 trials), "Advanced Solid Tumors or Hematologic Malignancies" (1 trials), "Extensive-stage Small Cell Lung Cancer" (1 trials) and "Stage IV Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Gemeinschaftspraxis Panagiotou/Minaei (GbR)" in a lesser frequency.
Clinical Trials Intervention Types at Gemeinschaftspraxis Panagiotou/Minaei (GbR)
Most popular intervention types in "Gemeinschaftspraxis Panagiotou/Minaei (GbR)" are "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "eHealth system support for symptom management via CANKADO" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Gemeinschaftspraxis Panagiotou/Minaei (GbR)
The vast majority of trials in "Gemeinschaftspraxis Panagiotou/Minaei (GbR)" are
2 trials for "All" genders.
Clinical Trials Status at Gemeinschaftspraxis Panagiotou/Minaei (GbR)
Currently, there are NaN active trials in "Gemeinschaftspraxis Panagiotou/Minaei (GbR)".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Gemeinschaftspraxis Panagiotou/Minaei (GbR),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Gemeinschaftspraxis Panagiotou/Minaei (GbR), 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".